Kristina Ganzinger received her PhD in Physical Chemistry from the University of Cambridge (United Kingdom) in 2015, under the guidance of Sir Prof. David Klenerman. After a postdoc at the Max Planck Institute for Biochemistry (Germany) with Prof. Petra Schwille, she began her current position as tenure-track group leader at the NWO physics institute AMOLF (Netherlands) in 2018.
Her main aim is to unravel how immune cells communicate with each other, both in natural and immunotherapy contexts: how do immune cells use molecular signaling pathways to transmit, process, and respond to information, both precisely and unambiguously?
Her lab’s approach is to address these questions by (1) in vitro reconstitution in model-membrane systems (“minimal cells”) and (2) pairing these studies with live- cell experiments. They use custom microscopy, quantitative data analysis and, in collaboration, predictive mathematical modelling to understand the underlying molecular mechanisms, and for this continuously develop new (single-molecule) microscopy methods. Her group is passionate about open access science and sharing methods via github (see https://github.com/GanzingerLaband https://ganzingerlab.github.io/K2TIRF/index.html) and pre-prints.
Kristina’s current research addresses:
- Signaling pathway reconstruction: we use a hybrid in vitro-in vivo approach, interfacing in vitro cell surface models with immune cells. In her previous research, Kristina found that the spatiotemporal reorganization of T-cell signaling molecules is key to initiate and control T cell signalling.
- Engineering signaling pathways: Her group pioneers the application of the same biophysics approach to understand the man-designed signaling networks in immunotherapeutics against cancer e.g., chimeric antigen receptors (CARs) signaling, with the aim of making these therapies more effective.
- Signaling in synthetic cells: Her group develops methods for the in vitro reconstitution of signaling molecules in lipid vesicles, the groundwork for her goal to develop synthetic cells that communicate with each other and with living cells.